This study is looking at a new way to screen for Barrett's esophagus (a condition that can lead to esophageal cancer) in veterans. It's for people aged 40 to 85 who don't have ongoing heartburn or reflux but have other risk factors like obesity, tobacco use, or a family history of esophageal cancer. The study will use a non-endoscopic test called Esocheck/Esoguard, which involves swallowing a small balloon device to collect cells. Participants will also have a standard upper endoscopy (a procedure where a thin, flexible tube with a camera is used to look at your esophagus). The main goal is to see if the Esoguard test can accurately identify Barrett's esophagus or esophageal cancer, with results expected within 10 to 30 days.

Study design

This is an interventional study planning to enroll 400 participants. It is not specified if it is randomized or blinded.

What's involved

You would complete the Esocheck/Esoguard test and have a diagnostic upper endoscopy.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint, which is the diagnosis of Barrett's esophagus or esophageal adenocarcinoma, will be measured within 10 to 30 days.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.